
Blueprint Medicines Corporation
USD129.46
+0.18 (+0.14%)
CEO
Kathryn Haviland
IPO Date
2015-04-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$129.46
Prev. Close
$129.28
Day Low
$129.46
Day High
$129.46
52W Low
$73.04
52W High
$129.55
Market Cap
$8.36B
Volume
2.98M
| 4 Jun 2025 |
| Citigroup |
| Sell |
| Neutral |
| upgrade |
| 3 Jun 2025 | JMP Securities | Market Outperform | Market Perform | downgrade |
| 3 Jun 2025 | Wolfe Research | Outperform | Peer Perform | downgrade |
| 2 Jun 2025 | Scotiabank | Sector Outperform | Sector Perform | downgrade |
| 2 Jun 2025 | Wedbush | Outperform | Neutral | downgrade |
| 2 Jun 2025 | JP Morgan | Overweight | Neutral | downgrade |
| 2 Jun 2025 | Needham | Buy | Hold | downgrade |